NEW CASE STUDY Unlocking the power of process analytical technology to boost downstream operations    Dive in today!
Contact Us
Contact Us

AGC Biologics

Three workers in AGC Biologics Milan site review fill/finish procedures

3 min read

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"

October 23, 2025 at 12:00 AM
Cell & Gene Therapy Press Release
Read press release
Seattle site team member hard at work

2 min read

Seattle Facility Achieves Regulatory Approvals, Customer Satisfaction and Zero-Finding ISO Certification Inspection

September 10, 2025 at 8:00 AM
Read press release
Graphic with AGC Biologics and Autolus logos and notes EU market authorization for AUCATZYL

1 min read

European Commission Approves CAR-T Therapy With Lentiviral Vectors Manufactured by AGC Biologics

July 31, 2025 at 7:00 AM
Read press release

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

July 29, 2025 at 7:00 AM
Press Release
Read press release
AGC Bio Seattle and Chiba site buildings

1 min read

From Seattle to Chiba: Okayama University Taps AGC Biologics' Global Pathway for New Therapeutic

July 16, 2025 at 5:00 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics Yokohama Cell Therapy Suites

2 min read

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need

June 25, 2025 at 5:02 PM
Press Release
Read press release
cell therapy services from AGC Biologics will support Quell Therapies

2 min read

AGC Biologics Partners with Quell Therapeutics to Advance T-Regulatory Cell Therapies for Immune Disorders

May 15, 2025 at 3:45 AM
Press Release
Read press release
AGC Biologics to support Novelty Nobility for antibody drug candidate

2 min read

AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate

May 5, 2025 at 4:00 PM
Press Release
Read press release
AGC Biologics Yokohama Facility begins GMP production in 2027

2 min read

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

April 7, 2025 at 3:51 PM
Press Release
Read press release
AGC Biologics announces new cell and gene business division

3 min read

AGC Biologics Launches New Dedicated Cell and Gene Business Division

April 2, 2025 at 12:25 PM
Press Release
Read press release
1 2 3 4 Next